Background {#sec0005}
==========

*Raoultella ornithinolytica* (formerly *Klebsiella ornithinolytica*) is a Gram-negative bacillus that belongs to the *Enterobacteriaceae* family [@bib0005]. Its role in the pathogenesis of human infections has recently been recognized [@bib0010]. Bone and joint infection caused by *R. ornithinolytica* is rare [@bib0010]. In this paper, we report the successful treatment of the first case of prosthetic joint infection caused by *R. ornithinolytica* with a two-stage prosthetic exchange and six-months of antimicrobial treatment.

Clinical presentation {#sec0010}
=====================

In November 2014, a 67-year-old French male was admitted to our center for a loosening of both the femoral and acetabular components of his right hip arthroplasty. He had a medical history of chronic obstructive pulmonary disease, peripheral artery disease and arterial hypertension. He had received a left hip prosthesis in 2003 and a right hip prosthesis in 2004 for degenerative arthritis. In April 2009, he underwent fixation of the right femur fracture. Few weeks following surgery, he presented with a painful right hip; cultures of periprosthetic effusion aspirate were negative. In 2010, he underwent plate osteosynthesis for the right periprosthetic femur fracture. Two years later, he present with worsening right hip pain that limited hip mobility.

In 2014, he presented to our medical center for evaluation. He denied fever. Laboratory investigations revealed a leukocyte count of 9000 μL^−1^, low hemoglobin concentration (8.3 g/l; normal = 135--175 g/l), normal platelet count of 400,000 μL^−1^ and high C-reactive protein levels (72 mg/l; normal values ≤5mg/l). The hip radiograph revealed loosening of both the femoral and acetabular components of the right hip prosthesis ([Fig. 1](#fig0005){ref-type="fig"}) and ^18^F FDG PET/CT showed right hip hypermetabolism, compatible with infected hip prosthesis with effusion ([Fig. 2](#fig0010){ref-type="fig"}). Microbiological cultures of the periprosthetic effusion were positive for *R. ornithinolytica,* as identified by MALDI-TOF mass spectrometry and 16 s rRNA gene sequencing. Antimicrobial susceptibility testing showed that the isolate was susceptible to amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, ceftriaxone, ciprofloxacin, doxycycline, aminoglycosides and cotrimoxazole, and was resistant to amoxicillin, ticarcillin and rifampin. A two-stage prosthetic exchange was performed with retention of plate osteosynthesis for the right periprosthetic femur fracture ([Fig. 3](#fig0015){ref-type="fig"}). He was treated with one-month curse of intravenous ceftriaxone 2 g once daily and oral ciprofloxacin 500 mg three times daily, followed by five-month of oral doxycycline 200 mg twice daily and oral ciprofloxacin 500 mg three times daily. He recovered and a new hip prosthesis was implanted in April 2015. No relapse was observed during the one-year post-antimicrobial follow-up.

Discussion {#sec0015}
==========

This paper presents the first known case of chronic prosthetic joint infection caused by *R. ornithinolytica* which were successfully treated with a two-stage prosthetic exchange and six months treatment with antimicrobials. *R. ornithinolytica* is a Gram-negative aquatic-commensal *Enterobacteriaceae* [@bib0015] and its pathogenic role in community and hospital-acquired infections such as cholangitis, intravascular catheter-related infections, urinary tract infections, skin infections, lower respiratory tract infections, central nervous system infections, mediastinitis, pericarditis, conjunctivitis and otitis has recently been elucidated [@bib0010].

To our knowledge, only five cases of chronic osteomyelitis have been reported to date, including one case of osteomyelitis of a distal phalanx of the right ring finger [@bib0020], one case of tibia pandiaphyseal osteomyelitis (an osteomyelitis extending to the entire the diaphysis or as involvement of the opposite metaphysis), two cases of chronic osteomyelitis of diabetic foot infections and one case of foot osteomyelitis related to a peripheral artery disease [@bib0010].

The main treatment of the cases of osteoarticular infection caused by *R. ornithinolytica* reported in the literature has been surgical lavage and debridement followed by prolonged antimicrobial treatment. The duration of treatment varied from 30 to 90 days [@bib0010], [@bib0020]. All of these cases recovered, but one case of tibia pandiaphysitis and one case of chronic osteomyelitis in diabetic foot infection required amputation [@bib0010]. Based on the duration of symptoms was more than one year and retention of plate osteosynthesis for the right periprosthetic femur fracture, we decided to treat our case with a two-stage prosthetic exchange and six months of antimicrobial therapy. A good clinical outcome was achieved.

Cases of *R*. *ornithinolytica* may be misidentified as a *Klebsiella* species in clinical laboratories using conventional phenotypic identification [@bib0025] and therefore the organisms may be under-recognized as a human pathogen [@bib0010].

*R. ornithinolytica* appears to be a Gram-negative aquatic-commensal Enterobacteriaceae with the ability to adhere to human tissues and to form biofilms in urinary catheters [@bib0030], [@bib0035]. These two mechanisms could play a role in the pathogenesis of bone and joint infections caused by *R. ornithinolytica*. The identification of virulence factors in the genomic study of clinical isolates is important to understanding the mechanisms by which *R. ornithinolytica* infects bone and orthopedic devices.

Conclusion {#sec0020}
==========

Although bone and joint infections due to *R. ornithinolytica* are rare, the organism should not be dismissed as a contaminant when isolated from surgical samples and the diagnosis should be further investigated. Prolonged antimicrobial treatment following surgical debridement and lavage is needed.
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![The hip radiograph revealed loosening of both the femoral and acetabular components of the right hip prosthesis.](gr1){#fig0005}

![^18^F FDG PET/CT showed a right hip hypermetabolism, compatible with infected hip prosthesis with effusion.](gr2){#fig0010}

![The hip radiograph showed a spacer prostheses in two-stage prosthesis exchange and retention of plate osteosynthesis.](gr3){#fig0015}
